Acipimox reduces circulating levels of insulin and associated neutrophilic inflammation in metabolic syndrome.
Montecucco F, Bertolotto M, Vuilleumier N, Franciosi U, Puddu A, Minetti S, Delrio A, Quercioli A, Bergamini E, Ottonello L, Pende A, Lenglet S, Pelli G, Mach F, Dallegri F, Viviani GL.
Montecucco F, et al. Among authors: pende a.
Am J Physiol Endocrinol Metab. 2011 Apr;300(4):E681-90. doi: 10.1152/ajpendo.00527.2010. Epub 2011 Jan 25.
Am J Physiol Endocrinol Metab. 2011.
PMID: 21266669
Free article.
Clinical Trial.